HealthQuill Drugs
Overuse of antibiotics
Drugs Pharma Research

India superbug crisis: 83% carry antibiotic-resistant bacteria, Lancet study

HQ Team November 19, 2025: An international study published in The Lancet’s eClinicalMedicine journal has exposed the devastating scale of India’s antimicrobial resistance.

Read More
The European Medicines Agency has allowed marketing authorisation for the Covid-19 variant vaccine made by Pfizer and BioNTech SE for children aged six months and older, according to a joint statement.
Drugs Research

Smart drug becomes a guided missile for cancer RNA

HQ Team  15 November, 2025: Scientists at the Hebrew University of Jerusalem have unveiled the first drug-like molecule purpose-built to seek out and shred a previously.

Read More
Drugs Research

Statins shown to boost breast cancer survival rates

HQ Team November 5, 2025: A new study reveals that initiating statin therapy within three years of an early-stage breast cancer diagnosis can.

Read More
Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency often ignored by caretakers.
Drugs Research

Genes, personality, family history strong predictors of alcohol addiction in teens

HQ Team November 3, 2025: A new study published in Alcohol: Clinical and Experimental Research shines a spotlight on the role of genes,.

Read More
Pfizer Inc., a US pharmaceutical company founded in 1849, has signed an agreement with the Trump administration to lower prices of prescription medicines in the North American nation
Drugs Pharma

Global drug supply relies heavily on China and India, warn reports

HQ Team October 31, 2025:  A new German study reveals that Europe is significantly dependent on China for essential medicines and their chemical components..

Read More
Antibiotic-resistant infections may kill 39.1 million people in the next 25 years equating to three deaths a minute, a global study finds.
Drugs Research

New potent antibiotic discovery offers new hope in fight against superbugs

HQ Team October 30, 2025: Research teams from the University of Warwick and Monash University Chemists have discovered a promising new antibiotic that.

Read More
A new weapon to kill superbugs may be on the horizon after Harvard researchers created a synthetic compound called cresomycin.
Drugs Health

HIV’s shape-shifting protein reveals clues for smarter drug design

A study from the Salk Institute has found HIV’s ability to hijack human cells, uncovering a shape-shifting viral protein that could transform treatments for the.

Read More
The European Union approved AstraZeneca Plc and Amgen Inc.’s add-on therapy to treat adults with a chronic inflammatory condition of the nasal passages.
Drugs Health Pharma

AstraZeneca, Amgen’s drug for nasal inflammation gets EU nod

The European Union approved AstraZeneca Plc and Amgen Inc.’s add-on therapy to treat adults with a chronic inflammatory condition of the nasal passages.

Read More
China’s Innovent Biologics and Takeda Pharmaceutical Co. announced a $11.4 billion licensing deal, which will enable the former to speed up the development of its immuno-oncology and antibody-drug conjugate cancer therapies.
Drugs Health Pharma

China’s Innovent, Japan’s Takeda in $11.4 billion deal for cancer therapies

China’s Innovent Biologics and Takeda Pharmaceutical Co. announced a $11.4 billion licensing deal, which will enable the former to speed up the development.

Read More
Hologic Inc., which specialises in women’s health diagnostics, is set to be acquired in a deal worth $18.3 billion backed by asset managers Blackstone and TGP.
Drugs Health Pharma

Asset managers Blackstone, TGP to acquire Hologic for $18.3 billion

Hologic Inc., which specialises in women’s health diagnostics, is set to be acquired in a deal worth $18.3 billion backed by asset managers.

Read More